What is Constelltn Bnds's earnings per share (EPS)?

Constelltn Bnds (STZ) reported diluted earnings per share of $9.61 for fiscal year 2026. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Constelltn Bnds Financials

STZ

Source SEC Filings (10-K/10-Q) Updated Feb 28, 2026 Currency USD FYE February

This page shows Constelltn Bnds (STZ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI STZ FY2025 2026-04-22

Cash generation stayed intact even as reported profit collapsed, revealing a business distorted by non-cash balance-sheet resets.

FY2025’s negative net income sits beside $3.2B of operating cash flow and $1.9B of free cash flow, while goodwill fell by about $2.9B and total assets by about $4.0B from FY2024. That combination suggests the weakest earnings line came far more from non-cash asset remeasurement than from a comparable decline in cash moving through the business.

Gross margin stayed around 50% through the last three years and reached 52.1% in FY2025. Yet operating margin fell from 31.8% in FY2024 to 3.5%, implying the damage sat below product cost rather than in the core markup on what the company sells.

FY2025 ended with just $68.1M of cash and a current ratio of 0.9x. Even so, the business produced $1.9B of free cash flow and returned roughly $1.9B through buybacks and dividends, showing a cash-throughput model that relies more on recurring internal cash generation than on holding a large cash buffer.

Financial Health Signals

Financial Profile 51/100

Based on FY2026 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Constelltn Bnds's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Constelltn Bnds has an operating margin of 29.8%, meaning the company retains $30 of operating profit per $100 of revenue. This strong profitability earns a score of 72/100, reflecting efficient cost management and pricing power. This is up from 3.5% the prior year.

Growth

Constelltn Bnds's revenue declined 10.5% year-over-year, from $10.2B to $9.1B. This contraction results in a growth score of 26/100.

Leverage

Constelltn Bnds carries a low D/E ratio of 1.20, meaning only $1.20 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 78/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Constelltn Bnds's current ratio of 1.08 is below the typical benchmark, resulting in a score of 17/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Constelltn Bnds converts 19.6% of revenue into free cash flow ($1.8B). This strong cash generation earns a score of 71/100.

Returns

Constelltn Bnds's ROE of 20.9% shows moderate profitability relative to equity, earning a score of 41/100. This is up from -1.2% the prior year.

Altman Z-Score Grey Zone

2.85

Constelltn Bnds scores 2.85, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Neutral

5/9

Constelltn Bnds passes 5 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.58x

For every $1 of reported earnings, Constelltn Bnds generates $1.58 in operating cash flow ($2.7B OCF vs $1.7B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

7.5x

Constelltn Bnds earns $7.5 in operating income for every $1 of interest expense ($2.7B vs $361.6M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$9.1B

YoY-10.5%

5Y CAGR+1.2%

10Y CAGR+2.4%

Constelltn Bnds generated $9.1B in revenue in fiscal year 2026. This represents a decrease of 10.5% from the prior year.

EBITDA

$3.1B

YoY+291.7%

5Y CAGR+0.3%

10Y CAGR+4.7%

Constelltn Bnds's EBITDA was $3.1B in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 291.7% from the prior year.

Net Income

$1.7B

YoY+2172.1%

5Y CAGR-3.3%

10Y CAGR+4.8%

Constelltn Bnds reported $1.7B in net income in fiscal year 2026. This represents an increase of 2172.1% from the prior year.

EPS (Diluted)

$9.61

Constelltn Bnds earned $9.61 per diluted share (EPS) in fiscal year 2026.

Cash & Balance Sheet

Free Cash Flow

$1.8B

YoY-7.4%

5Y CAGR-1.6%

10Y CAGR+13.1%

Constelltn Bnds generated $1.8B in free cash flow in fiscal year 2026, representing cash available after capex. This represents a decrease of 7.4% from the prior year.

Cash & Debt

$102.4M

YoY+50.4%

5Y CAGR-26.0%

10Y CAGR+2.1%

Constelltn Bnds held $102.4M in cash against $9.7B in long-term debt as of fiscal year 2026.

Dividends Per Share

$4.08

Constelltn Bnds paid $4.08 per share in dividends in fiscal year 2026.

Shares Outstanding

172M

Constelltn Bnds had 172M shares outstanding in fiscal year 2026.

Margins & Returns

Gross Margin

51.5%

YoY-0.5pp

5Y CAGR-0.3pp

10Y CAGR+10.8pp

Constelltn Bnds's gross margin was 51.5% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 0.5 percentage points from the prior year.

Operating Margin

29.8%

YoY+26.3pp

5Y CAGR-2.6pp

10Y CAGR+5.4pp

Constelltn Bnds's operating margin was 29.8% in fiscal year 2026, reflecting core business profitability. This is up 26.3 percentage points from the prior year.

Net Margin

18.5%

YoY+19.3pp

5Y CAGR-4.7pp

10Y CAGR+3.9pp

Constelltn Bnds's net profit margin was 18.5% in fiscal year 2026, showing the share of revenue converted to profit. This is up 19.3 percentage points from the prior year.

Return on Equity

20.9%

YoY+22.1pp

5Y CAGR+6.2pp

10Y CAGR+4.8pp

Constelltn Bnds's ROE was 20.9% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 22.1 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$924.1M

YoY-17.8%

10Y CAGR+39.2%

Constelltn Bnds spent $924.1M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 17.8% from the prior year.

Capital Expenditures

$875.0M

YoY-27.9%

5Y CAGR+0.2%

10Y CAGR-0.2%

Constelltn Bnds invested $875.0M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 27.9% from the prior year.

STZ Income Statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Revenue	$9.1B-10.5%	$10.2B+2.5%	$10.0B+5.4%	$9.5B+7.2%	$8.8B+2.4%	$8.6B
Cost of Revenue	$4.4B-9.5%	$4.9B-1.0%	$4.9B+5.6%	$4.7B+13.9%	$4.1B-0.9%	$4.1B
Gross Profit	$4.7B-11.3%	$5.3B+5.9%	$5.0B+5.2%	$4.8B+1.3%	$4.7B+5.4%	$4.5B
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$1.8B-5.2%	$1.9B+6.4%	$1.8B-4.9%	$1.9B+12.8%	$1.7B+2.1%	$1.7B
Operating Income	$2.7B+666.8%	$354.9M-88.8%	$3.2B+11.5%	$2.8B+21.9%	$2.3B-16.5%	$2.8B
Interest Expense	$361.6M-13.6%	$418.4M-5.7%	$443.6M+206.7%	-$415.9M	N/A	N/A
Income Tax	$621.0M+1301.2%	-$51.7M-111.3%	$456.6M+8.2%	$422.1M+36.4%	$309.4M-39.5%	$511.1M
Net Income	$1.7B+2172.1%	-$81.4M-104.7%	$1.7B+2533.0%	-$71.0M-75.7%	-$40.4M-102.0%	$2.0B
EPS (Diluted)	$9.61	N/A	N/A	N/A	N/A	N/A

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Revenue	$1.9B-13.6%	$2.2B-10.4%	$2.5B-1.4%	$2.5B+16.2%	$2.2B-12.2%	$2.5B-15.6%	$2.9B+9.7%	$2.7B
Cost of Revenue	N/A	$1.0B-11.2%	$1.2B-6.2%	$1.2B	N/A	$1.2B-16.2%	$1.4B+11.9%	$1.3B
Gross Profit	$951.7M-19.6%	$1.2B-9.7%	$1.3B+3.4%	$1.3B+13.6%	$1.1B-13.2%	$1.3B-15.0%	$1.5B+7.7%	$1.4B
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	$491.2M+12.7%	$436.0M-12.9%	$500.7M	N/A	$491.3M0.0%	$491.2M+6.3%	$462.2M
Operating Income	N/A	$692.0M-20.8%	$874.0M+22.4%	$713.8M	N/A	$793.0M+164.5%	-$1.2B-230.6%	$941.6M
Interest Expense	N/A	$86.6M-2.7%	$89.0M-11.5%	$100.6M	N/A	$107.7M+1.8%	$105.8M+1.0%	$104.8M
Income Tax	N/A	$110.1M-62.9%	$296.8M+238.8%	$87.6M	N/A	$44.5M+129.2%	-$152.2M-643.6%	$28.0M
Net Income	$201.8M-59.9%	$502.8M+7.9%	$466.0M-9.7%	$516.1M+237.5%	-$375.3M-160.9%	$615.9M+151.4%	-$1.2B-236.7%	$877.0M
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

STZ Balance Sheet

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Total Assets	$21.9B+1.1%	$21.7B-15.7%	$25.7B+4.2%	$24.7B-4.6%	$25.9B-4.6%	$27.1B
Current Assets	$2.9B-21.8%	$3.7B-0.4%	$3.7B+6.7%	$3.5B+5.0%	$3.3B+9.4%	$3.0B
Cash & Equivalents	$102.4M+50.4%	$68.1M-55.3%	$152.4M+14.2%	$133.5M-33.0%	$199.4M-56.7%	$460.6M
Inventory	$1.4B-0.2%	$1.4B-30.8%	$2.1B+9.5%	$1.9B+20.7%	$1.6B+21.8%	$1.3B
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$5.2B+2.1%	$5.1B-35.8%	$8.0B+0.7%	$7.9B+0.8%	$7.9B+0.9%	$7.8B
Total Liabilities	$13.5B-6.9%	$14.5B-7.1%	$15.6B-1.9%	$15.9B+15.4%	$13.8B+4.8%	$13.2B
Current Liabilities	$2.7B-33.3%	$4.0B+28.4%	$3.1B+5.8%	$3.0B+10.0%	$2.7B+112.7%	$1.3B
Long-Term Debt	$9.7B+4.3%	$9.3B-13.0%	$10.7B-5.4%	$11.3B+19.0%	$9.5B-8.9%	$10.4B
Total Equity	$8.1B+17.4%	$6.9B-29.4%	$9.7B+15.8%	$8.4B-28.3%	$11.7B-13.7%	$13.6B
Retained Earnings	$13.6B+7.7%	$12.6B-6.1%	$13.4B+8.7%	$12.3B-14.9%	$14.5B-4.1%	$15.1B

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Total Assets	$21.9B+1.0%	$21.7B+1.2%	$21.4B-3.8%	$22.3B+2.8%	$21.7B-5.1%	$22.8B-1.2%	$23.1B-11.4%	$26.1B
Current Assets	$2.9B-0.1%	$2.9B+1.0%	$2.9B-27.0%	$3.9B+6.1%	$3.7B+2.4%	$3.6B-0.5%	$3.6B-4.7%	$3.8B
Cash & Equivalents	$102.4M-32.8%	$152.4M+111.7%	$72.0M-2.6%	$73.9M+8.5%	$68.1M-7.6%	$73.7M+14.1%	$64.6M-12.5%	$73.8M
Inventory	$1.4B+4.0%	$1.4B-4.2%	$1.4B+2.0%	$1.4B-1.8%	$1.4B-32.5%	$2.1B+1.5%	$2.1B-1.3%	$2.1B
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$5.2B+0.8%	$5.2B+0.2%	$5.2B+0.4%	$5.2B+0.6%	$5.1B-8.7%	$5.6B-1.8%	$5.7B-28.4%	$8.0B
Total Liabilities	$13.5B-1.2%	$13.7B+0.4%	$13.6B-7.5%	$14.7B+1.5%	$14.5B-1.5%	$14.7B-1.3%	$14.9B-3.6%	$15.5B
Current Liabilities	$2.7B+23.8%	$2.2B-18.3%	$2.7B-28.0%	$3.7B-8.5%	$4.0B+22.7%	$3.3B+12.9%	$2.9B-6.7%	$3.1B
Long-Term Debt	$9.7B-5.8%	$10.3B+5.1%	$9.8B0.0%	$9.8B+5.4%	$9.3B-8.8%	$10.2B-4.7%	$10.7B0.0%	$10.7B
Total Equity	$8.1B+4.8%	$7.7B+2.8%	$7.5B+3.2%	$7.3B+5.6%	$6.9B-12.0%	$7.8B-0.7%	$7.9B-23.2%	$10.3B
Retained Earnings	$13.6B+0.2%	$13.6B+2.5%	$13.2B+2.2%	$12.9B+2.7%	$12.6B-4.2%	$13.2B+3.4%	$12.7B-9.8%	$14.1B

STZ Cash Flow Statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Operating Cash Flow	$2.7B-15.3%	$3.2B+13.4%	$2.8B+0.8%	$2.8B+1.9%	$2.7B-3.6%	$2.8B
Capital Expenditures	$875.0M-27.9%	$1.2B-4.3%	$1.3B+22.6%	$1.0B+0.8%	$1.0B+18.8%	$864.6M
Free Cash Flow	$1.8B-7.4%	$1.9B+28.3%	$1.5B-12.2%	$1.7B+2.6%	$1.7B-13.6%	$1.9B
Investing Cash Flow	$16.5M+101.7%	-$974.8M+24.2%	-$1.3B-28.7%	-$999.4M+3.5%	-$1.0B-1078.4%	-$87.9M
Financing Cash Flow	-$2.7B-17.4%	-$2.3B-53.4%	-$1.5B+19.0%	-$1.8B+5.7%	-$1.9B+17.8%	-$2.3B
Dividends Paid	$715.7M-2.2%	$731.8M+11.9%	$653.8M+11.2%	$587.7M+2.6%	$573.0M-0.3%	$575.0M
Share Buybacks	$924.1M-17.8%	$1.1B+350.1%	$249.7M-85.3%	$1.7B+22.3%	$1.4B	$0

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Operating Cash Flow	$562.8M-8.8%	$616.9M-27.6%	$852.1M+33.7%	$637.2M+7.1%	$594.7M-13.2%	$685.2M-42.0%	$1.2B+71.2%	$690.5M
Capital Expenditures	$218.9M-11.0%	$246.0M+13.2%	$217.3M+12.7%	$192.8M-31.8%	$282.6M+23.7%	$228.4M-30.3%	$327.8M-12.7%	$375.3M
Free Cash Flow	$343.9M-7.3%	$370.9M-41.6%	$634.8M+42.8%	$444.4M+42.4%	$312.1M-31.7%	$456.8M-46.5%	$854.0M+170.9%	$315.2M
Investing Cash Flow	-$213.6M+9.0%	-$234.7M-135.5%	$660.9M+437.0%	-$196.1M-258.9%	$123.4M+151.3%	-$240.6M+49.9%	-$480.2M-27.2%	-$377.4M
Financing Cash Flow	-$401.3M-33.1%	-$301.6M+80.1%	-$1.5B-246.3%	-$437.6M+39.5%	-$723.0M-66.3%	-$434.8M+38.8%	-$711.0M-80.9%	-$393.0M
Dividends Paid	$176.9M-0.6%	$177.9M-0.8%	$179.4M-1.5%	$182.2M+0.9%	$180.5M-1.6%	$183.4M+0.1%	$183.3M-1.1%	$185.3M
Share Buybacks	$100.0M-54.6%	$220.1M-26.1%	$297.9M-2.7%	$306.1M-32.8%	$455.7M+108.2%	$218.9M-12.2%	$249.2M+24.6%	$200.0M

STZ Financial Ratios

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Gross Margin	51.5%-0.5pp	52.1%+1.7pp	50.4%-0.1pp	50.4%-2.9pp	53.4%+1.5pp	51.8%
Operating Margin	29.8%+26.3pp	3.5%-28.3pp	31.8%+1.7pp	30.1%+3.7pp	26.4%-6.0pp	32.4%
Net Margin	18.5%+19.3pp	-0.8%-18.1pp	17.3%+18.1pp	-0.8%-0.3pp	-0.5%-23.6pp	23.2%
Return on Equity	20.9%+22.1pp	-1.2%-18.9pp	17.7%+18.6pp	-0.8%-0.5pp	-0.3%-15.0pp	14.7%
Return on Assets	7.7%+8.1pp	-0.4%-7.1pp	6.7%+7.0pp	-0.3%-0.1pp	-0.2%-7.5pp	7.4%
Current Ratio	1.08+0.2	0.92-0.3	1.190.0	1.18-0.1	1.23-1.2	2.40
Debt-to-Equity	1.20-0.2	1.35+0.3	1.10-0.2	1.34+0.5	0.81+0.0	0.77
FCF Margin	19.6%+0.7pp	19.0%+3.8pp	15.2%-3.0pp	18.2%-0.8pp	19.0%-3.5pp	22.5%

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Gross Margin	49.6%-3.7pp	53.2%+0.4pp	52.8%+2.4pp	50.4%-1.1pp	51.5%-0.6pp	52.1%+0.3pp	51.8%-0.9pp	52.7%
Operating Margin	N/A	31.1%-4.1pp	35.2%+6.9pp	28.4%	N/A	32.2%+74.3pp	-42.1%-77.5pp	35.4%
Net Margin	10.5%-12.1pp	22.6%+3.8pp	18.8%-1.7pp	20.5%+37.9pp	-17.3%-42.3pp	25.0%+66.1pp	-41.1%-74.0pp	33.0%
Return on Equity	2.5%-4.0pp	6.5%+0.3pp	6.2%-0.9pp	7.1%+12.6pp	-5.5%-13.3pp	7.9%+23.1pp	-15.2%-23.8pp	8.6%
Return on Assets	0.9%-1.4pp	2.3%+0.1pp	2.2%-0.1pp	2.3%+4.0pp	-1.7%-4.4pp	2.7%+7.9pp	-5.2%-8.6pp	3.4%
Current Ratio	1.08-0.3	1.34+0.3	1.08+0.0	1.07+0.1	0.92-0.2	1.10-0.1	1.25+0.0	1.23
Debt-to-Equity	1.20-0.1	1.33+0.0	1.30-0.0	1.350.0	1.35+0.0	1.30-0.1	1.36+0.3	1.04
FCF Margin	17.9%+1.2pp	16.7%-8.9pp	25.6%+7.9pp	17.7%+3.3pp	14.4%-4.1pp	18.5%-10.7pp	29.3%+17.4pp	11.8%

Similar Companies

Ambev ABEV

$52.6B

Fomento Mexicano FMX

$41.3B

Anheuser Busch BUD

$155.7B

Molson Coors Beverage TAP

$7.9B

Boston Beer SAM

$2.1B

Frequently Asked Questions

What is Constelltn Bnds's annual revenue?

Constelltn Bnds (STZ) reported $9.1B in total revenue for fiscal year 2026. This represents a -10.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Constelltn Bnds's revenue growing?

Constelltn Bnds (STZ) revenue declined by 10.5% year-over-year, from $10.2B to $9.1B in fiscal year 2026.

Is Constelltn Bnds profitable?

Yes, Constelltn Bnds (STZ) reported a net income of $1.7B in fiscal year 2026, with a net profit margin of 18.5%.

What is Constelltn Bnds's EBITDA?

Constelltn Bnds (STZ) had EBITDA of $3.1B in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Constelltn Bnds have?

As of fiscal year 2026, Constelltn Bnds (STZ) had $102.4M in cash and equivalents against $9.7B in long-term debt.

What is Constelltn Bnds's gross margin?

Constelltn Bnds (STZ) had a gross margin of 51.5% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Constelltn Bnds's operating margin?

Constelltn Bnds (STZ) had an operating margin of 29.8% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Constelltn Bnds's net profit margin?

Constelltn Bnds (STZ) had a net profit margin of 18.5% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Does Constelltn Bnds pay dividends?

Yes, Constelltn Bnds (STZ) paid $4.08 per share in dividends during fiscal year 2026.

What is Constelltn Bnds's return on equity (ROE)?

Constelltn Bnds (STZ) has a return on equity of 20.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Constelltn Bnds's free cash flow?

Constelltn Bnds (STZ) generated $1.8B in free cash flow during fiscal year 2026. This represents a -7.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Constelltn Bnds's operating cash flow?

Constelltn Bnds (STZ) generated $2.7B in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Constelltn Bnds's total assets?

Constelltn Bnds (STZ) had $21.9B in total assets as of fiscal year 2026, including both current and long-term assets.

What are Constelltn Bnds's capital expenditures?

Constelltn Bnds (STZ) invested $875.0M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Does Constelltn Bnds buy back shares?

Yes, Constelltn Bnds (STZ) spent $924.1M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

How many shares does Constelltn Bnds have outstanding?

Constelltn Bnds (STZ) had 172M shares outstanding as of fiscal year 2026.

What is Constelltn Bnds's current ratio?

Constelltn Bnds (STZ) had a current ratio of 1.08 as of fiscal year 2026, which is considered adequate.

What is Constelltn Bnds's debt-to-equity ratio?

Constelltn Bnds (STZ) had a debt-to-equity ratio of 1.20 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Constelltn Bnds's return on assets (ROA)?

Constelltn Bnds (STZ) had a return on assets of 7.7% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Constelltn Bnds's Altman Z-Score?

Constelltn Bnds (STZ) has an Altman Z-Score of 2.85, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Constelltn Bnds's Piotroski F-Score?

Constelltn Bnds (STZ) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Constelltn Bnds's earnings high quality?

Constelltn Bnds (STZ) has an earnings quality ratio of 1.58x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Constelltn Bnds cover its interest payments?

Constelltn Bnds (STZ) has an interest coverage ratio of 7.5x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Constelltn Bnds?

Constelltn Bnds (STZ) scores 51 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.